PMID- 32845247 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201003 IS - 1929-0748 (Print) IS - 1929-0748 (Electronic) IS - 1929-0748 (Linking) VI - 9 IP - 8 DP - 2020 Aug 26 TI - Aftercare of Childhood Cancer Survivors in Switzerland: Protocol for a Prospective Multicenter Observational Study. PG - e18898 LID - 10.2196/18898 [doi] LID - e18898 AB - BACKGROUND: Most children and adolescents diagnosed with cancer become long-term survivors. For most of them, regular follow-up examinations to detect and treat late effects are necessary, especially in adulthood. The transition from pediatric to adult-focused follow-up care is a critical moment for childhood cancer survivors (CCSs); a substantial proportion of CCSs are lost to follow-up in this transition process and do not attend follow-up care in adulthood. This can have serious effects on survivors' health if late effects are not discovered in a timely fashion. OBJECTIVE: In this study, we primarily assess the current follow-up situation, related needs, and knowledge of adolescent and young adult CCSs who have transitioned from pediatric to adult-focused follow-up care. As secondary objectives, we evaluate transition readiness, identify facilitating factors of transition and adherence to long-term follow-up (LTFU) care, and compare three different transition models. METHODS: The Aftercare of Childhood Cancer Survivors (ACCS) Switzerland study is a prospective, multicenter, observational study that was approved by the ethics committee in February 2019. We are recruiting CCSs from three pediatric oncology centers and using questionnaires to answer the study questions. RESULTS: To date, we have recruited 58 participants. The study is ongoing, and recruitment of participants will continue until January 2021. CONCLUSIONS: The ACCS study will provide information on CCSs' preferences and expectations for follow-up care and their transition into the adult setting. The results will help improve the LTFU care and cancer knowledge of CCSs and subsequently enhance adherence to follow-up care and reduce loss to follow-up in adulthood. TRIAL REGISTRATION: ClinicalTrials.gov NCT04284189; https://clinicaltrials.gov/ct2/show/NCT04284189?id=NCT04284189. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/18898. CI - (c)Sibylle Denzler, Maria Otth, Katrin Scheinemann. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 26.08.2020. FAU - Denzler, Sibylle AU - Denzler S AUID- ORCID: 0000-0001-6282-6295 AD - Division of Oncology-Hematology, Department of Pediatrics, Kantonsspital Aarau, Aarau, Switzerland. FAU - Otth, Maria AU - Otth M AUID- ORCID: 0000-0002-2839-502X AD - Division of Oncology-Hematology, Department of Pediatrics, Kantonsspital Aarau, Aarau, Switzerland. AD - Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland. FAU - Scheinemann, Katrin AU - Scheinemann K AUID- ORCID: 0000-0002-3578-7152 AD - Division of Oncology-Hematology, Department of Pediatrics, Kantonsspital Aarau, Aarau, Switzerland. AD - Division of Oncology-Hematology, University Children's Hospital Basel, Basel, Switzerland. AD - University of Basel, Basel, Switzerland. AD - Department of Pediatrics, McMaster Children's Hospital, Hamilton, ON, Canada. AD - McMaster University, Hamilton, ON, Canada. LA - eng SI - ClinicalTrials.gov/NCT04284189 PT - Journal Article DEP - 20200826 PL - Canada TA - JMIR Res Protoc JT - JMIR research protocols JID - 101599504 PMC - PMC7481869 OTO - NOTNLM OT - Switzerland OT - childhood cancer survivors OT - long-term follow-up care OT - transition COIS- Conflicts of Interest: None declared. EDAT- 2020/08/28 06:00 MHDA- 2020/08/28 06:01 PMCR- 2020/08/26 CRDT- 2020/08/27 06:00 PHST- 2020/03/26 00:00 [received] PHST- 2020/07/07 00:00 [accepted] PHST- 2020/07/04 00:00 [revised] PHST- 2020/08/27 06:00 [entrez] PHST- 2020/08/28 06:00 [pubmed] PHST- 2020/08/28 06:01 [medline] PHST- 2020/08/26 00:00 [pmc-release] AID - v9i8e18898 [pii] AID - 10.2196/18898 [doi] PST - epublish SO - JMIR Res Protoc. 2020 Aug 26;9(8):e18898. doi: 10.2196/18898.